Science Explorer Back to mapMap

Acute Myocardial Infarction Research

Acute Myocardial Infarction Research is a research topic within Cardiology and Cardiovascular Medicine. Science Explorer counts 45k research works in it since 1950. 10.0% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the management, diagnosis, and treatment of acute myocardial infarction (heart attacks), including topics such as ST-segment elevation, troponin assays, thrombolytic therapy, primary angioplasty, and risk assessment. It also includes guidelines and recommendations for the management of acute coronary syndromes and cardiovascular disease.

  • Myocardial Infarction
  • Acute Coronary Syndromes
  • ST-Segment Elevation
  • Primary Angioplasty
  • Troponin Assays
  • Cardiovascular Disease
  • Guidelines
  • Thrombolytic Therapy
  • Risk Score
  • Reperfusion Therapy
Research works
45k
fractional, since 1950
In the world top 10%
4.5k
per year above
Top-10% rate
10.0%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+3%
the tick is no change
Largest producer
United States
36% of the 10 largest, 2022-now
Acute Myocardial Infarction Research

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Acute Myocardial Infarction Research research?

By volume, the United States and China publish the most (2k and 973 works in 2022-now).

By volume, 2022-now

  1. 1 United States 2k works
  2. 2 China 973 works
  3. 3 United Kingdom 422 works
  4. 4 Italy 369 works
  5. 5 India 335 works
  6. 6 Japan 328 works
  7. 7 Germany 305 works
  8. 8 Spain 302 works
  9. 9 Pakistan 299 works
  10. 10 Australia 254 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 35.7%China: 17.4%United Kingdom: 7.6%Italy: 6.6%6 others listed: 32.7%36%largest
United States1,992 · 35.7%China973 · 17.4%United Kingdom422 · 7.6%Italy369 · 6.6%6 others listed1,822 · 32.7%

Shares of the rows listed above, not of the whole node.

Which institutions lead Acute Myocardial Infarction Research research?

By volume in 2022-now, Harvard University publishes the most Acute Myocardial Infarction Research research, followed by Capital Medical University and Chinese Academy of Medical Sciences & Peking Union Medical College.

Who are the leading researchers in Acute Myocardial Infarction Research?

The most-cited researchers publishing on Acute Myocardial Infarction Research include David Moher, Douglas G. Altman and Christopher J L Murray.

  1. 1 David Moher Canada 898k citations
  2. 2 Douglas G. Altman United Kingdom 862k citations
  3. 3 Christopher J L Murray United States 583k citations
  4. 4 Theo Vos United States 439k citations
  5. 5 George Davey Smith United Kingdom 435k citations
  6. 6 Ali H. Mokdad United States 429k citations
  7. 7 Walter Churchill Willett United States 411k citations
  8. 8 Robert John Tibshirani United States 396k citations
  9. 9 John J.V. McMurray United Kingdom 349k citations
  10. 10 Hermann Brenner Germany 343k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Acute Myocardial Infarction Research?

The most cited paper in Acute Myocardial Infarction Research is "Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study" (Salim Yusuf, Steven Hawken, Stephanie Ôunpuu et al., 2004), with 12,111 citations. Next come "2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation" (9,924) and "ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary" (8,374).

Most cited papers
#PaperReleasedCitations
1 Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study Salim Yusuf, Steven Hawken, Stephanie Ôunpuu et al. · The Lancet Open access Sep 2004 12,111
2 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation Borja Ibáñez et al. · European Heart Journal Open access127 authors 26 Aug 2017 9,924
3 ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary Elliott Marshall Antman et al. · Circulation 2 Aug 2004 8,374
4 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Marco Roffi et al. · European Heart Journal Open access118 authors 29 Aug 2015 8,343
5 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes Juhani M. Knuuti et al. · European Heart Journal Open access163 authors 31 Aug 2019 7,293
All 95 most cited papers, with filters and sorting

Where is Acute Myocardial Infarction Research research done?

The largest centres of Acute Myocardial Infarction Research research in 2022-now are Beijing (China), London (United Kingdom), New York (United States) and Seoul (South Korea). Among places with at least 20 works in it, it is an unusually large share of all research in Peshawar.

Largest cities, 2022-now

  1. 1 BeijingChina 208 works
  2. 2 LondonUnited Kingdom 125 works
  3. 3 New YorkUnited States 109 works
  4. 4 SeoulSouth Korea 105 works
  5. 5 KarachiPakistan 103 works
  6. 6 MadridSpain 98 works
  7. 7 MoscowRussia 84 works
  8. 8 BostonUnited States 79 works
  9. 9 TokyoJapan 79 works
  10. 10 ParisFrance 73 works

Where it is the local speciality

  1. PeshawarPK · 54.4 works10×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Acute Myocardial Infarction Research than the world average.

See Acute Myocardial Infarction Research on the map

Where is the best place to study Acute Myocardial Infarction Research?

Among universities, judged by research, Harvard University, University of Copenhagen and University of Turku score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 18.56%fractional works in this field (log) →share of work in the world top 10% →University of TurkuDuke UniversityHarvard UniversityUniversity of Copenh…
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 73.817.9%3.3×82 -15.6%
2University of CopenhagenDenmark 66.111.7%5.1×38 +40.8%
3University of TurkuFinland 65.930.7%3.8×10 +21.1%
4Duke UniversityUnited States 64.619.6%3.3×22 +16.1%
5Stanford UniversityUnited States 64.121.9%1.8×21 +27.5%
6University of TorontoCanada 61.717.0%2.0×32 +4.7%
7Humanitas UniversityItaly 61.619.9%8.6×10 +37.4%
8Johns Hopkins UniversityUnited States 61.417.5%2.5×30 +0.9%
9Karolinska InstitutetSweden 61.418.2%6.1×27 -22.6%
10Aarhus UniversityDenmark 60.911.2%3.5×24 +43.8%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Acute Myocardial Infarction Research, country by country

Is Acute Myocardial Infarction Research research growing?

Output in 2022-2025 was 3% higher than in 2018-2021, peaking in 2021. The fastest-growing topics are Acute Myocardial Infarction Research.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Acute Myocardial Infarction Research as a percentage of every work published that year, 0.033% in 2024.

still counting0.020%0.040%0.060%Acute Myocardial Infarction Research0.036% in 202519801990200020102020

Fractional works of Acute Myocardial Infarction Research over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Acute Myocardial Infarction Research10.0% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Acute Myocardial Infarction Research. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.